Skip to Main Content

Author Details

Michael J Robertson
Stanford University School of Medicine
2015
42
25
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36411392Insights into distinct signaling profiles of the µOR activated by diverse agonists.Nat Chem Biol2023
37160876Structural basis for activation of CB1 by an endocannabinoid analog.Nat Commun2023
37290962Hexahydroquinoline Derivatives Are Selective Agonists for the Adhesion G Protein-Coupled Receptor ADGRG1/GPR56.Mol Pharmacol2023
36450356Structure-based design of bitopic ligands for the µ-opioid receptor.Nature2023
34281791Drug discovery in the era of cryo-electron microscopy.Trends Biochem Sci2022
35804245Author Correction: Plasticity in ligand recognition at somatostatin receptors.Nat Struct Mol Biol2022
35687850Development of OPLS-AA/M Parameters for Simulations of G Protein-Coupled Receptors and Other Membrane Proteins.J Chem Theory Comput2022
35418682The tethered peptide activation mechanism of adhesion GPCRs.Nature2022
36396979Structure determination of inactive-state GPCRs with a universal nanobody.Nat Struct Mol Biol2022
36171289Bespoke library docking for 5-HT<sub>2A</sub> receptor agonists with antidepressant activity.Nature2022
36064945Structural basis for recognition of N-formyl peptides as pathogen-associated molecular patterns.Nat Commun2022
36087581Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.Neuron2022
34880492Structure and mechanism of the SGLT family of glucose transporters.Nature2022
35241813The oxytocin signaling complex reveals a molecular switch for cation dependence.Nat Struct Mol Biol2022
35210615Plasticity in ligand recognition at somatostatin receptors.Nat Struct Mol Biol2022
34194039G-protein activation by a metabotropic glutamate receptor.Nature2021
34433062Structural insights into GIRK2 channel modulation by cholesterol and PIP<sub>2</sub>.Cell Rep2021
34659874Isolating Conformers to Assess Dynamics of Peptidic Catalysts Using Computationally Designed Macrocyclic Peptides.ACS Catal2021
34194040Asymmetric activation of the calcium-sensing receptor homodimer.Nature2021
32413291GemSpot: A Pipeline for Robust Modeling of Ligands into Cryo-EM Maps.Structure2020
31945772Structure of the M2 muscarinic receptor-β-arrestin complex in a lipid nanodisc.Nature2020
31945771Structure of the neurotensin receptor 1 in complex with β-arrestin 1.Nature2020
32946782Structure of a Hallucinogen-Activated Gq-Coupled 5-HT<sub>2A</sub> Serotonin Receptor.Cell2020
32580208Structures of metabotropic GABA<sub>B</sub> receptor.Nature2020
30639101Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.Cell2019
32296768Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds.ACS Pharmacol Transl Sci2019
31528808Development and Validation of the Quantum Mechanical Bespoke Protein Force Field.ACS Omega2019
30814739Author Correction: Structural insights into the activation of metabotropic glutamate receptors.Nature2019
31073061Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes.Science2019
30807148Development and Testing of the OPLS-AA/M Force Field for RNA.J Chem Theory Comput2019
30675062Structural insights into the activation of metabotropic glutamate receptors.Nature2019
29575754Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.ChemMedChem2018
30687577Molecular Dynamics Simulations of a Conformationally Mobile Peptide-Based Catalyst for Atroposelective Bromination.ACS Catal2018
28627890Improved Description of Sulfur Charge Anisotropy in OPLS Force Fields: Model Development and Parameterization.J Phys Chem B2017
29479109Improved Treatment of Nucleosides and Nucleotides in the OPLS-AA Force Field.Chem Phys Lett2017
29259749Adding a Hydrogen Bond May Not Help: Naphthyridinone vs Quinoline Inhibitors of Macrophage Migration Inhibitory Factor.ACS Med Chem Lett2017
27156768Irregularities in enzyme assays: The case of macrophage migration inhibitory factor.Bioorg Med Chem Lett2016
28105287Systematic Study of Effects of Structural Modifications on the Aqueous Solubility of Drug-like Molecules.ACS Med Chem Lett2016
27299179A Fluorescence Polarization Assay for Binding to Macrophage Migration Inhibitory Factor and Crystal Structures for Complexes of Two Potent Inhibitors.J Am Chem Soc2016
27441982Performance of Protein-Ligand Force Fields for the Flavodoxin-Flavin Mononucleotide System.J Phys Chem Lett2016
25697265Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factor.J Am Chem Soc2015
26190950Improved Peptide and Protein Torsional Energetics with the OPLSAA Force Field.J Chem Theory Comput2015
  • 1 - 42 of 42

Recommended Authors

Salk Institute for Biological Studies
Career Start Year 2014
Number of shared co-authors 0
Skolkovo Institute of Science and Technology
Career Start Year 2013
Number of shared co-authors 9
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 2010
Number of shared co-authors 1
Department of Pharmaceutical Sciences, University of California San Francisco
Career Start Year 2009
Number of shared co-authors 10
Blavatnik Institute, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 8
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 2008
Number of shared co-authors 8
Lilly Research Laboratories
Career Start Year 2006
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 2006
Number of shared co-authors 0
ShanghaiTech University, China iHuman Institute
Career Start Year 2006
Number of shared co-authors 4
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 1
Uppsala University
Career Start Year 2004
Number of shared co-authors 4
College of Biotechnology and Bioengineering, Zhejiang University of Technology
Career Start Year 2001
Number of shared co-authors 3
University of California
Career Start Year 2001
Number of shared co-authors 2
Columbia University
Career Start Year 2000
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 5
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 1
Pennsylvania State University College of Medicine
Career Start Year 1998
Number of shared co-authors 0
Boston University
Career Start Year 1997
Number of shared co-authors 2
Laufer Center for Physical and Quantitative Biology, Stony Brook University
Career Start Year 1994
Number of shared co-authors 0
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1993
Number of shared co-authors 2
Bridge Institute, University of Southern California
Career Start Year 1991
Number of shared co-authors 6
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 1
Lilly Research Laboratories
Career Start Year 1990
Number of shared co-authors 0
Center for Molecular Biology (ZMBH), Heidelberg University
Career Start Year 1989
Number of shared co-authors 1
iHuman Institute, ShanghaiTech University
Career Start Year 1988
Number of shared co-authors 6
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 0
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 2
University of Michigan ann arbor
Career Start Year 1974
Number of shared co-authors 1
Institute for Computational Biomedicine
Career Start Year 1973
Number of shared co-authors 2
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 1

Collaborators

Stanford University School of Medicine
Co-authored papers 28
Stanford University School of Medicine
Co-authored papers 9
Co-authored papers 8
UNC Chapel Hill School of Medicine
Co-authored papers 5
Stanford University School of Medicine
Co-authored papers 5
University of North Carolina at Chapel Hill
Co-authored papers 4
Stanford University School of Medicine
Co-authored papers 3
University of North Carolina School of Medicine
Co-authored papers 3
University of North Carolina School of Medicine
Co-authored papers 2
Eshelman School of Pharmacy, University of North Carolina
Co-authored papers 2
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 2
Utrecht University
Co-authored papers 2
Stanford University
Co-authored papers 1
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Co-authored papers 1
University of Washington
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
University of North Carolina School of Medicine
Co-authored papers 1
University of North Carolina School of Medicine
Co-authored papers 1
Co-authored papers 1
Department of Pharmaceutical Technology and Biopharmacy, University of Groningen
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
University of North Carolina at Chapel Hill
Co-authored papers 1
Stanford University School of Medicine, Stanford University
Co-authored papers 1
University of North Carolina School of Medicine
Co-authored papers 1
UNC School of Medicine
Co-authored papers 1
Co-authored papers 1
School of Pharmacy, University of Wisconsin-Madison
Co-authored papers 1
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1